Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Galderma Group AG
Pharmaceutical Preparation ManufacturingSwitzerland
Last verified 27 days agogalderma.com
Galderma Group AG, a leading player in the pharmaceutical preparation manufacturing industry, is headquartered in Switzerland (CH). Founded in 1981, the company has established itself as a pioneer in dermatology and aesthetic medicine, focusing on innovative solutions for skin health. With a strong presence in Europe, North America, and Asia, Galderma is renowned for its diverse portfolio, which includes products like Restylane and Dysport, designed to enhance skin appearance and treat various dermatological conditions.
Galderma's commitment to research and development has led to significant milestones, positioning it as a trusted name in the market. The company's unique formulations and dedication to safety and efficacy have garnered numerous accolades, solidifying its reputation as a leader in skin care and aesthetic treatments.
32
DitchCarbon score
-10 vs industry average
Galderma Group AG’s score of 32 is lower than 44% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Galderma Group AG?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2026
2020202120222023202420252026
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Galderma Group AG's reported carbon emissions
Galderma Group AG, a Pharmaceutical Preparation Manufacturing company headquartered in Switzerland, reported its 2023 greenhouse gas emissions. Their Scope 1 emissions were 7,600,000 kg CO2e, and Scope 2 (market-based) emissions were 700,000 kg CO2e. Scope 3 emissions totalled 332,100,000 kg CO2e.
In 2022, Galderma Group AG's Scope 1 emissions were 9,800,000 kg CO2e, and Scope 2 (market-based) emissions were 4,200,000 kg CO2e. Scope 3 emissions for 2022 were 332,100,000 kg CO2e. The company's emissions data is self-reported and not cascaded from a parent organisation. Galderma Group AG currently does not have publicly available documented emissions reduction targets, SBTi targets, or a commitment to the Climate Pledge.
Assessing Galderma Group AG as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Galderma Group AG and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Galderma Group AG’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Galderma Group AG yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Galderma Group AG27 days ago
32
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more